PKO Investment Management Joint-Stock’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Buy
3,700
+400
+12% +$224K 0.14% 119
2026
Q1
$1.85M Buy
3,300
+200
+6% +$128K 0.16% 113
2025
Q4
$2.1M Buy
3,100
+500
+19% +$341K 0.17% 109
2025
Q3
$1.66M Buy
2,600
+1,900
+271% +$1.15M 0.14% 124
2025
Q2
$375K Sell
700
-2,600
-79% -$1.24M 0.04% 162
2025
Q1
$1.39M Buy
3,300
+500
+18% +$217K 0.16% 102
2024
Q4
$1.16M Buy
2,800
+2,100
+300% +$921K 0.14% 97
2024
Q3
$354K Sell
700
-700
-50% -$340K 0.04% 147
2024
Q2
$682K Buy
1,400
+700
+100% +$351K 0.08% 135
2024
Q1
$380K Hold
700
0.05% 147
2023
Q4
$389K Sell
700
-700
-50% -$329K 0.05% 135
2023
Q3
$612K Buy
1,400
+700
+100% +$349K 0.08% 116
2023
Q2
$352K Hold
700
0.04% 134
2023
Q1
$350K Sell
700
-400
-36% -$191K 0.05% 133
2022
Q4
$449K Hold
1,100
0.07% 121
2022
Q3
$358K Hold
1,100
0.06% 121
2022
Q2
$386K Buy
+1,100
New +$449K 0.06% 115

Other funds holding IDXX

PKO Investment Management Joint-Stock's IDXX Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, buying an estimated $224K and bringing the position to 3,700 shares worth $1.95M. The position accounts for 0.14% of the portfolio, ranked #119.

PKO Investment Management Joint-Stock first reported a position in IDXX in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.1M in Q4 2025. 545 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • PKO Investment Management Joint-Stock held 3,700 shares of Idexx Laboratories worth $1.95M as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 400 Idexx Laboratories shares in Q2 2026, an estimated $224K.
  • Idexx Laboratories made up 0.14% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #119 holding.
  • PKO Investment Management Joint-Stock first reported a position in Idexx Laboratories in Q2 2022 and has held it in 17 quarters since.
  • PKO Investment Management Joint-Stock's Idexx Laboratories position peaked at $2.1M in Q4 2025.
  • 545 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.